Please login to the form below

Not currently logged in
Email:
Password:

Pharma must step up monitoring of social media

New service intends to help keep track of online patient communications

Social media has been a rising point of concern for pharma companies with regards to the monitoring of patient communications about drug safety, but a new service could help track online activities.

Patient reports have been notoriously hard to rack on tools such as Facebook and Twitter, leading to such regulatory concerns such as Roche last year, with the Swiss pharma company found to have “serious shortcomings” with regards to pharmacovigilance practices following an investigation by the European Medicines Agency (EMA).

Life sciences consulting company YourEncore says its new service to track social media communications – which evolved from previous work with a pharma company - could help avert future regulatory breaches such as those committed by Roche.

“Drug makers may have hundreds of patient outreach programmes worldwide gathering patient safety information every day without the required regulatory controls,” said Pam Holland, YourEncore's managing director, life sciences.

“We help ensure that all past and future safety information is handled according to the law.”

The service was developed after YourEncore experts visit an unnamed pharma firm's operations across more than 20 countries, reviewing its patient outreach programmes in order to identify shortcomings and enhance reporting standards.

Regulatory agencies are also doing more to help pharma companies comply with the pharmacovigilance rules amid the rise of online technologies.

This includes the publication at the start of the year of draft FDA guidance on 'interactive promotional media', encompassing Twitter, Facebook and blogs.

Article by
Tara Craig

2nd April 2014

From: Marketing, Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics